Tampa Free Press on MSN
Rare GLP-1 vision loss risks fuel growing gray market supply chain concerns
A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, ...
Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden ...
News Nation on MSN
GLP-1 drugs connected to rare vision issue, researchers say
A study at Rutgers University found the medications may be connected to a higher likelihood of ischemic optic neuropathy.
Use of GLP-1 RAs is associated with a higher risk for ischemic optic neuropathy compared with SGLT2is and DPP4is.
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...
A new study found a small increase in the risk of a rare type of sudden vision loss among adults taking GLP-1 medications for ...
Morning Overview on MSN
Doctors warn that semaglutide has been tied to sudden vision loss in one eye
Three of the most widely prescribed semaglutide drugs, Ozempic, Rybelsus, and Wegovy, are now linked to reports of sudden ...
The Toxic Avenger will open in theaters in 2025. This review is based on a screening of The Toxic Avenger at Fantastic Fest 2023. Troma Entertainment peaked during the rental-store reign of colorful, ...
In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase ...
Optometrists Anastasia Logotheti, OD, and Andrew Pucker, OD, discuss strategies for mitigating the impact of topical glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results